beta-alanine has been researched along with carbostyril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H; Kawamura, Y | 1 |
| Hussar, DA | 1 |
2 other study(ies) available for beta-alanine and carbostyril
| Article | Year |
|---|---|
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
New Drugs 2019, part 1.
Topics: Aminophenols; Aminopyridines; Antibodies, Monoclonal, Humanized; Benzoates; Benzodioxoles; beta-Alanine; Bridged Bicyclo Compounds, Heterocyclic; cis-trans-Isomerases; Drug Approval; Drug Combinations; Glucagon-Like Peptides; Humans; Indoles; Quinolones; United States; United States Food and Drug Administration | 2019 |